Literature DB >> 25646899

Cancer control capacity in 50 low- and middle-income countries.

Rolando Camacho1, Cecilia Sepúlveda2, Diogo Neves1, Marion Piñeros1, Maria Villanueva1, Jean-Marie Dangou3, Ibtihal Fadhil4, Gauden Galea5, Renu Garg6, Silvana Luciani7.   

Abstract

Within the World Health Organization-International Atomic Energy Agency (WHO-IAEA) collaboration for delivery of technical assistance to its Member States, the National Cancer Control Programme/Plan (NCCP) Core Capacity Self-Assessment Tool has been used to obtain a simple and quick qualitative overview of national cancer control planning and on-going activities. The NCCP tool was applied in 50 Member States, which were classified as low- and middle-income countries in 2012. Results show that half of these countries reported having officially endorsed an NCCP and 42% were in the process of preparing or updating one. Overall, the most relevant cancer control interventions reported to be partially developed or well established in most countries were related to the cancer prevention, early detection of cervical and breast cancers, as well as diagnosis and treatment of curable cancers. Contrarily, patient's rehabilitation, psychosocial support, human papilloma virus vaccination, breast cancer screening with mammography and control of occupational carcinogens were noted as being in early development phases. The availability of crucial resources to support interventions was perceived to be the highest in upper middle-income countries. These findings highlight specific areas where WHO, IAEA and partners could strengthen collaboration with countries to leverage on-going interventions and improve availability of resources.

Entities:  

Keywords:  International Atomic Energy Agency; National Cancer Control Programme/Plan; World Health Organization; cancer control; low- and middle-income countries

Mesh:

Year:  2015        PMID: 25646899     DOI: 10.1080/17441692.2015.1007469

Source DB:  PubMed          Journal:  Glob Public Health        ISSN: 1744-1692


  3 in total

Review 1.  Cancer in sub-Saharan Africa: a Lancet Oncology Commission.

Authors:  Wilfred Ngwa; Beatrice W Addai; Isaac Adewole; Victoria Ainsworth; James Alaro; Olusegun I Alatise; Zipporah Ali; Benjamin O Anderson; Rose Anorlu; Stephen Avery; Prebo Barango; Noella Bih; Christopher M Booth; Otis W Brawley; Jean-Marie Dangou; Lynette Denny; Jennifer Dent; Shekinah N C Elmore; Ahmed Elzawawy; Diane Gashumba; Jennifer Geel; Katy Graef; Sumit Gupta; Serigne-Magueye Gueye; Nazik Hammad; Laila Hessissen; Andre M Ilbawi; Joyce Kambugu; Zisis Kozlakidis; Simon Manga; Lize Maree; Sulma I Mohammed; Susan Msadabwe; Miriam Mutebi; Annet Nakaganda; Ntokozo Ndlovu; Kingsley Ndoh; Jerry Ndumbalo; Mamsau Ngoma; Twalib Ngoma; Christian Ntizimira; Timothy R Rebbeck; Lorna Renner; Anya Romanoff; Fidel Rubagumya; Shahin Sayed; Shivani Sud; Hannah Simonds; Richard Sullivan; William Swanson; Verna Vanderpuye; Boateng Wiafe; David Kerr
Journal:  Lancet Oncol       Date:  2022-05-09       Impact factor: 54.433

2.  Determinants of cancer screening awareness and participation among Indonesian women.

Authors:  Sumadi L Anwar; Gindo Tampubolon; Mieke Van Hemelrijck; Susanna H Hutajulu; Johnathan Watkins; Wahyu Wulaningsih
Journal:  BMC Cancer       Date:  2018-03-06       Impact factor: 4.430

3.  Advancing Reliable Data for Cancer Control in the Central America Four Region.

Authors:  Marion Piñeros; Silvina Frech; Lindsay Frazier; Mathieu Laversanne; Joaquin Barnoya; Claudia Garrido; Eduardo Gharzouzi; Andrea Chacón; Soad Fuentes Alabi; Lisseth Ruiz de Campos; Jacqueline Figueroa; Ricardo Dominguez; Ofelia Rojas; Rosario Pereira; Carla Rivera; Douglas R Morgan
Journal:  J Glob Oncol       Date:  2017-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.